Q32 Bio (QTTB) Institutional Ownership $2.57 +0.14 (+5.76%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$2.57 +0.00 (+0.16%) As of 02/21/2025 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Q32 Bio (NASDAQ:QTTB)CurrentInstitutional OwnershipPercentage31.32%Number ofInstitutional Buyers(last 12 months)46TotalInstitutional Inflows(last 12 months)$110.61MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$308.29K Get QTTB Insider Trade Alerts Want to know when executives and insiders are buying or selling Q32 Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data QTTB Institutional Buying and Selling by Quarter Q32 Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/19/2025 Public Employees Retirement System of Ohio7,540$26K0.0%N/A0.062% 2/17/2025 Squarepoint Ops LLC19,009$65K0.0%N/A0.156% 2/17/2025 Two Sigma Investments LP53,175$183K0.0%N/A0.437% 2/17/2025 Trustees of Columbia University in the City of New York133,903$461K0.1%N/A1.099% 2/17/2025 Sanofi244,083$840K0.5%N/A2.004% 2/17/2025 Millennium Management LLC10,725$37K0.0%-89.3%0.088% 2/17/2025 Jacobs Levy Equity Management Inc.34,844$120K0.0%N/A0.286% 2/17/2025 Deutsche Bank AG25,018$86K0.0%+699.8%0.205% 2/17/2025 Cubist Systematic Strategies LLC12,249$42K0.0%N/A0.101% 2/17/2025 Ameriprise Financial Inc.15,548$53K0.0%N/A0.128% Get the Latest News and Ratings for QTTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Q32 Bio and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 ArrowMark Colorado Holdings LLC81,482$280K0.0%N/A0.669% 2/17/2025 Acorn Capital Advisors LLC803,425$2.76M1.5%N/A6.596% 2/13/2025 Mariner LLC121,427$418K0.0%N/A0.997% 2/13/2025 Townsquare Capital LLC17,466$60K0.0%N/A0.143% 2/13/2025 Raymond James Financial Inc.10,746$37K0.0%N/A0.088% 2/11/2025 AXQ Capital LP10,581$36K0.0%N/A0.087% 2/10/2025 Monaco Asset Management SAM574,816$1.98M0.3%N/A4.719% 2/6/2025 Raymond James Financial Inc.10,746$37K0.0%N/A0.088% 2/3/2025 Hussman Strategic Advisors Inc.10,500$36K0.0%N/A0.086% 1/30/2025 Rhumbline Advisers105,544$363K0.0%+1,164.3%0.867% 1/29/2025 Savant Capital LLC15,281$53K0.0%N/A0.125% 1/27/2025 Bleakley Financial Group LLC43,360$149K0.0%N/A0.356% 1/22/2025 Drive Wealth Management LLC10,928$38K0.0%N/A0.090% 11/27/2024 Franklin Resources Inc.4,857$225K0.0%N/A0.040% 11/19/2024 Barclays PLC10,443$465K0.0%+105.2%0.086% 11/16/2024 Geode Capital Management LLC131,768$5.88M0.0%+22.4%1.082% 11/15/2024 Barclays PLC10,443$465K0.0%+105.2%0.086% 11/15/2024 Jane Street Group LLC16,437$733K0.0%N/A0.135% 11/15/2024 State Street Corp110,164$4.92M0.0%+35.5%0.904% 11/15/2024 Point72 Asset Management L.P.76,685$3.42M0.0%N/A0.630% 11/14/2024 Eventide Asset Management LLC190,000$8.48M0.1%N/A1.560% 11/14/2024 MetLife Investment Management LLC3,563$159K0.0%N/A0.029% 11/13/2024 BNP Paribas Financial Markets1,298$58K0.0%+199.1%0.011% 11/13/2024 FMR LLC426,302$19.02M0.0%+137.3%3.500% 10/23/2024 Values First Advisors Inc.741$33K0.0%N/A0.006% 8/13/2024 Ensign Peak Advisors Inc64,481$1.16M0.0%+150.6%0.540% 8/9/2024 Renaissance Technologies LLC14,764$265K0.0%N/A0.124% 8/9/2024 Harvard Management Co. Inc.162,965$2.93M0.2%N/A1.365% 8/1/2024 Rhumbline Advisers7,658$137K0.0%+11,681.5%0.064% 7/26/2024 Bank of New York Mellon Corp17,569$315K0.0%N/A0.147% Watch This Robotics Demo Before March 17th (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo…5/17/2024 Ikarian Capital LLC22,335$381K0.0%N/A0.685% 5/15/2024 ARCH Venture Management LLC320,482$5.46M6.5%N/A9.831% 5/15/2024 Affinity Asset Advisors LLC27,777$473K0.1%N/A0.852% 5/14/2024 Platinum Investment Management Ltd.109,964$1.87M0.1%N/A3.373% 5/10/2024 Acadian Asset Management LLC3,695$62K0.0%N/A0.113% 5/10/2024 Vanguard Group Inc.107,752$1.84M0.0%N/A3.305% 5/6/2024 Atlas Venture Life Science Advisors LLC2,092,106$35.65M3.3%N/A64.254% 5/3/2024 Carlyle Group Inc.1,102,741$18.07M1.1%N/A33.826% 4/23/2024 BML Capital Management LLC24,894$424K0.3%N/A0.764% 4/22/2024 Vivo Capital LLC370,068$6.31M0.5%N/A11.366% (Data available from 1/1/2016 forward) QTTB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of QTTB shares? During the previous two years, 47 institutional investors and hedge funds held shares of Q32 Bio. The most heavily invested institutionals were Atlas Venture Life Science Advisors LLC ($35.65M), FMR LLC ($19.02M), Carlyle Group Inc. ($18.07M), Eventide Asset Management LLC ($8.48M), Vivo Capital LLC ($6.31M), Geode Capital Management LLC ($5.88M), and ARCH Venture Management LLC ($5.46M).Learn more on QTTB's institutional investors. What percentage of Q32 Bio stock is owned by institutional investors? 31.32% of Q32 Bio stock is owned by institutional investors. Learn more on QTTB's institutional investor holdings. Which institutional investors have been buying Q32 Bio stock? Of the 46 institutional investors that purchased Q32 Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Atlas Venture Life Science Advisors LLC ($2.09M), Carlyle Group Inc. ($1.10M), Acorn Capital Advisors LLC ($803.43K), Monaco Asset Management SAM ($574.82K), Vivo Capital LLC ($370.07K), ARCH Venture Management LLC ($320.48K), and FMR LLC ($246.66K). How much institutional buying is happening at Q32 Bio? Institutional investors have bought a total of 7,377,146 shares in the last 24 months. This purchase volume represents approximately $110.61M in transactions. Which Q32 Bio major shareholders have been selling company stock? The following institutional investors have sold Q32 Bio stock in the last 24 months: Millennium Management LLC ($89.62K). How much institutional selling is happening at Q32 Bio? Institutional investors have sold a total of 89,618 shares in the last 24 months. This volume of shares sold represents approximately $308.29K in transactions. Related Companies Inventiva Institutional Ownership Renovaro Institutional Ownership Telomir Pharmaceuticals Institutional Ownership Caribou Biosciences Institutional Ownership Invizyne Technologies Institutional Ownership Milestone Pharmaceuticals Institutional Ownership Ventyx Biosciences Institutional Ownership InflaRx Institutional Ownership Eupraxia Pharmaceuticals Institutional Ownership Cassava Sciences Institutional Ownership This page (NASDAQ:QTTB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Q32 Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Q32 Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.